International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Ondansetron Hydrochloride 0.8mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2007 - Diabetes
View All Articles in Issue

Page(s): 158

Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ondansetron Hydrochloride 0.8mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: ondansetron, nausea, vomiting, cancer chemotherapy, 5HT-3 blocker, 5 hydroxytryptamine-3 receptor antagonist

Related Categories: CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 158
Ondansetron Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 339
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr	Mar/Apr 2004 Pg. 126-129
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy	Nov/Dec 2014 Pg. 520-525
Nausea and Vomiting in Hospice Patients Boomsma Diane	Jul/Aug 2000 Pg. 250-251
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio	May/Jun 2017 Pg. 255-263
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 76-82
Granisetron 0.05-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 222
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Zur Eyal	Mar/Apr 2013 Pg. 113-123
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Moon Richard B	Mar/Apr 2006 Pg. 95-98
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Mishkan Emilyn S	Sep/Oct 2005 Pg. 339-346
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report McNulty Jack P	May/Jun 2007 Pg. 212-218
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Mar/Apr 2008 Pg. 156-160
Granisetron 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 66
Return to Top